Embecta Corp
$10.01
(as of Jun 6, 9:30 AM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Embecta Corp
Stock Price
$10.01
Ticker Symbol
EMBC
Exchange
NASDAQ
Industry Information for Embecta Corp
Sector
Healthcare
Industry
Medical Instruments & Supplies
Company Description for Embecta Corp
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Fundamentals for Embecta Corp
Market Capitalization
$614,815,296
EBITDA
$83,800,000
Dividends per Share
$0.60
P/E Ratio
11.74
Forward P/E Ratio
0
Earnings per Share
$0.89
Earnings per Share Estimate Next Year
Profit Margin
4.89%
Shares Outstanding
58,442,500
Percent Owned by Insiders
0.47%
Percent Owned by Institutions
101.22%
52-Week High
52-Week Low
Technical Indicators for Embecta Corp
Analyst Ratings for Embecta Corp
Strong Buy
1
Buy
0
Hold
3
Sell
1
Strong Sell
0
News About Embecta Corp
May 27, 2025, 5:00 PM EST
PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
See more.
May 22, 2025, 6:30 AM EST
PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase its phased approach for value creation and present its long range financial plan (“LRP”).
See more.
May 13, 2025, 10:50 AM EST
This story was originally published on MedTech Dive. See more.
May 9, 2025, 12:10 PM EST
Embecta Corp. See more.